Human Antibody Screening
World-class Antibody Library
(Ymax®-ABL)
Human antibody screening refers to the process of selecting multiple monophage antibodies that specifically bind to the target antigen from a human antibody library. The selection is made based on the binding affinity between the antigen and the phage antibody. The human antibody library used in biopanning is Ymax®-ABL, which has been developed by Y-Biologics using its own technology and boasts vast diversity comparable to world-class antibody libraries.
Ymax®-ABL
(Human Naïve library)-
Human Naïve
(scFv Iibrary)
cDNA library -
Diversity > 1011
(Heavy chain : 2.35 × 108 /
Light chain : 5.77 × 107) -
Minimal immunogenicity and toxicity
(Naïve cDNA library
derived from B cells) -
A specialized screening service for companies seeking to develop new antibody drugs
One & Only High-Capacity
Automated System in Korea
The monophage antibody analysis and individual clone selection process, which is a time-consuming and labor-intensive part of the screening process, are carried out using the one and only cutting-edge high-capacity automated system in Korea to derive monoclonal antibodies within just 3 months.
Automated equipment
-
01HT Colony Picking System
-
02Liquid Handling System
-
03Automated Washer
-
04Automated ELISA
Human Body Screening Process
01Differentiated Services
-
Use of the Ymax®-ABL human antibody library with great diversity that has been developed by Y-Biologics using its own technology
-
Derivation of antibodies within 3 months using the one and only cutting-edge high-capacity automated system in Korea
-
Services provided by a team of experts on antibody drug development to ensure the success of your project
* The development schedule may vary depending on the specifics of the project.
02Screening Process
-
4 WEEKS
Biopanning (3 rounds)
-
4 WEEKS
Human body screening
-
1 WEEKS
Monophage analysis
-
2 WEEKS
Final report
-
Optional
IgG production